Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1985 1
1988 1
1989 1
1992 2
1993 1
1994 1
1995 4
1996 2
1997 4
1998 5
1999 2
2000 4
2001 4
2002 4
2003 4
2004 4
2005 2
2006 4
2007 2
2008 3
2009 1
2010 2
2011 3
2012 2
2013 1
2014 3
2015 2
2018 1
2019 1
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. O'Leary JG, et al. Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12. Gastroenterology. 2019. PMID: 30986390 Review.
BEST PRACTICE ADVICE 1: Global tests of clot formation, such as rotational thromboelastometry, thromboelastography, sonorheometry, and thrombin generation, may eventually have a role in the evaluation of clotting in patients with cirrhosis, but currently lack validated tar …
BEST PRACTICE ADVICE 1: Global tests of clot formation, such as rotational thromboelastometry, thromboelastography, sonorheometry, and th
COVID-19 coagulopathy - what should we treat?
Chowdary P. Chowdary P. Exp Physiol. 2022 Jul;107(7):749-758. doi: 10.1113/EP089404. Epub 2022 Jun 22. Exp Physiol. 2022. PMID: 35733235 Free PMC article. Review.
NEW FINDINGS: What is the topic of this review? Overview of the coagulation abnormalities, including elevated D-dimers widely reported with COVID-19, often labelled as COVID coagulopathy. ...ABSTRACT: Coronavirus disease 19 (COVID-19) causes acute lung injury with diffuse …
NEW FINDINGS: What is the topic of this review? Overview of the coagulation abnormalities, including elevated D-dimers widely reporte …
Clot Waveform Analysis for Hemostatic Abnormalities.
Wada H, Shiraki K, Matsumoto T, Shimpo H, Shimaoka M. Wada H, et al. Ann Lab Med. 2023 Nov 1;43(6):531-538. doi: 10.3343/alm.2023.43.6.531. Epub 2023 Jun 30. Ann Lab Med. 2023. PMID: 37387486 Free PMC article. Review.
Clot waveform analysis (CWA) observes changes in transparency in a plasma sample based on clotting tests such as activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT). Evidence indicates that not only an abnormal waveform but also peak …
Clot waveform analysis (CWA) observes changes in transparency in a plasma sample based on clotting tests such as activated partial thrombopl …
Disseminated intravascular coagulation: testing and diagnosis.
Wada H, Matsumoto T, Yamashita Y, Hatada T. Wada H, et al. Clin Chim Acta. 2014 Sep 25;436:130-4. doi: 10.1016/j.cca.2014.04.020. Epub 2014 Apr 30. Clin Chim Acta. 2014. PMID: 24792730 Review.
Abnormalities of the hemostatic system in patients with DIC result from the sum of vectors for hypercoagulation and hyperfibrinolysis. ...Both the antithrombin (AT) and protein C (PC) levels are significantly low in patients with septic DIC, and reduced amounts of AT and P
Abnormalities of the hemostatic system in patients with DIC result from the sum of vectors for hypercoagulation and hyperfibrinolysis
Adverse effects of glucocorticoids: coagulopathy.
Coelho MC, Santos CV, Vieira Neto L, Gadelha MR. Coelho MC, et al. Eur J Endocrinol. 2015 Oct;173(4):M11-21. doi: 10.1530/EJE-15-0198. Epub 2015 May 13. Eur J Endocrinol. 2015. PMID: 25971647 Review.
Consequently, there is a shortening of activated partial thromboplastin time and increased thrombin generation. For these reasons, anticoagulant prophylaxis might be considered in patients with CS whenever they have concomitant prothrombotic risk factors. ...
Consequently, there is a shortening of activated partial thromboplastin time and increased thrombin generation. For these reasons, an …
Mechanisms of hypercoagulability.
Dahl OE. Dahl OE. Thromb Haemost. 1999 Aug;82(2):902-6. Thromb Haemost. 1999. PMID: 10605801 Review.
Subsequently, venous bloodborne procoagulant debris induce a substantial thrombin generation as blood passes the lung capillaries. Thus, the lungs seem to have a central role in the mechanisms of hypercoagulability in high-risk patients. ...Several predisposing genetic and …
Subsequently, venous bloodborne procoagulant debris induce a substantial thrombin generation as blood passes the lung capillaries. Th …
Hemostasis and malignancy.
Francis JL, Biggerstaff J, Amirkhosravi A. Francis JL, et al. Semin Thromb Hemost. 1998;24(2):93-109. doi: 10.1055/s-2007-995829. Semin Thromb Hemost. 1998. PMID: 9579631 Review.
There is an increased incidence of thromboembolic disease in patients with cancers and hemostatic abnormalities are extremely common in such patients. Antihemostatic agents have been successfully used to treat a variety of experimental tumors, and several clinical trials i …
There is an increased incidence of thromboembolic disease in patients with cancers and hemostatic abnormalities are extremely common …
Sepsis and disseminated intravascular coagulation.
Levi M, de Jonge E, van der Poll T. Levi M, et al. J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):43-7. doi: 10.1023/B:THRO.0000014592.27892.11. J Thromb Thrombolysis. 2003. PMID: 14760211 Review.
Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation (DIC). ...Recent insights into important pathogenetic mechanisms that may lead to DIC have resulted in novel preventiv …
Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intr …
Laboratory diagnosis of dysfibrinogenemia.
Cunningham MT, Brandt JT, Laposata M, Olson JD. Cunningham MT, et al. Arch Pathol Lab Med. 2002 Apr;126(4):499-505. doi: 10.5858/2002-126-0499-LDOD. Arch Pathol Lab Med. 2002. PMID: 11900586 Free article. Review.
Dysfibrinogenemia is a coagulation disorder caused by a variety of structural abnormalities in the fibrinogen molecule that result in abnormal fibrinogen function. ...The inherited form is diagnosed by demonstrating similar laboratory test abnormalities in family me …
Dysfibrinogenemia is a coagulation disorder caused by a variety of structural abnormalities in the fibrinogen molecule that result in …
Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease.
Senchenkova E, Seifert H, Granger DN. Senchenkova E, et al. Semin Thromb Hemost. 2015 Sep;41(6):582-9. doi: 10.1055/s-0035-1556590. Epub 2015 Aug 13. Semin Thromb Hemost. 2015. PMID: 26270113 Review.
Although the underlying causes of the increased risk for thrombus development remain poorly understood, there is a large body of evidence suggesting that abnormalities in coagulation, fibrinolysis, and platelet function may contribute to this response. ...The animal studie …
Although the underlying causes of the increased risk for thrombus development remain poorly understood, there is a large body of evidence su …
75 results